Literature DB >> 23546657

Immunoisolation of nanoparticles containing endocytic vesicles for drug quantitation.

Ari Nowacek1, Irena Kadiu, JoEllyn McMillan, Howard E Gendelman.   

Abstract

Cell-mediated nanoparticle delivery has recently emerged as an efficacious method of delivering therapeutic agents across physiological barriers. Use of cells as nanodelivery vehicles requires accurate assessment of their loading capacity and identification of intracellular compartments where nanoparticles are sequestered. This is of great interest since specific endocytic trafficking routes can ultimately influence the mode of nanoparticle release and their efficacy and function. Here, we describe a technique that allows for the isolation of individual populations of nanoparticle-containing endosomes for subsequent quantitative analysis and more accurate description of where nanoparticles are stored on a subcellular level.

Entities:  

Mesh:

Year:  2013        PMID: 23546657      PMCID: PMC3930998          DOI: 10.1007/978-1-62703-336-7_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Nanoparticles and liposomes: a state of the art.

Authors:  P P Speiser
Journal:  Methods Find Exp Clin Pharmacol       Date:  1991-06

2.  Macrophage endocytic trafficking of antiretroviral nanoparticles.

Authors:  Irena Kadiu; Ari Nowacek; Joellyn McMillan; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2011-03-21       Impact factor: 5.307

Review 3.  Nanoparticles in drug delivery.

Authors:  S J Douglas; S S Davis; L Illum
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

  3 in total
  5 in total

1.  The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.

Authors:  Gang Zhang; Dongwei Guo; Prasanta K Dash; Mariluz Araínga; Jayme L Wiederin; Nicole A Haverland; Jaclyn Knibbe-Hollinger; Andrea Martinez-Skinner; Pawel Ciborowski; Val S Goodfellow; Tadeusz A Wysocki; Beata J Wysocki; Larisa Y Poluektova; Xin-Ming Liu; JoEllyn M McMillan; Santhi Gorantla; Harris A Gelbard; Howard E Gendelman
Journal:  Nanomedicine       Date:  2015-10-22       Impact factor: 5.307

2.  Modulating cellular autophagy for controlled antiretroviral drug release.

Authors:  Midhun B Thomas; Divya Prakash Gnanadhas; Prasanta K Dash; Jatin Machhi; Zhiyi Lin; JoEllyn McMillan; Benson Edagwa; Harris Gelbard; Howard E Gendelman; Santhi Gorantla
Journal:  Nanomedicine (Lond)       Date:  2018-08-21       Impact factor: 5.307

3.  Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.

Authors:  Benson J Edagwa; Dongwei Guo; Pavan Puligujja; Han Chen; JoEllyn McMillan; Xinming Liu; Howard E Gendelman; Prabagaran Narayanasamy
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

4.  Extracellular anti-angiogenic proteins augment an endosomal protein trafficking pathway to reach mitochondria and execute apoptosis in HUVECs.

Authors:  Mo Chen; Tao Qiu; Jiajie Wu; Yang Yang; Graham D Wright; Min Wu; Ruowen Ge
Journal:  Cell Death Differ       Date:  2018-03-09       Impact factor: 15.828

5.  A year-long extended release nanoformulated cabotegravir prodrug.

Authors:  Tanmay A Kulkarni; Aditya N Bade; Brady Sillman; Bhagya Laxmi Dyavar Shetty; Melinda S Wojtkiewicz; Nagsen Gautam; James R Hilaire; Sruthi Sravanam; Adam Szlachetka; Benjamin G Lamberty; Brenda M Morsey; Howard S Fox; Yazen Alnouti; JoEllyn M McMillan; R Lee Mosley; Jane Meza; Paul L Domanico; Tai-Yuen Yue; Gary Moore; Benson J Edagwa; Howard E Gendelman
Journal:  Nat Mater       Date:  2020-04-27       Impact factor: 47.656

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.